Moleculin Biotech Depreciation & Amortization 2011-2026 | MBRX

Annual Depreciation & Amortization Moleculin Biotech

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
90 K	126 K	127 K	130 K	164 K	200 K	199 K	68 K	18 K	6 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
200 K	6 K	113 K

Quarterly Depreciation & Amortization Moleculin Biotech

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21 K	29 K	31 K	-	31 K	31 K	32 K	-	32 K	31 K	30 K	-	32 K	34 K	32 K	-	41 K	44 K	44 K	-	57 K	52 K	46 K	-	51 K	49 K	48 K	-	11 K	7 K	8 K	-	5 K	5 K	4 K	-	1 K	1 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
57 K	1 K	29 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Amarin Corporation plc AMRN	3.02 M	$ 14.67	-0.07 %	$ 6.09 B	Irlanda
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Cabaletta Bio CABA	1.65 M	$ 2.82	1.44 %	$ 283 M	USA
Avid Bioservices CDMO	11.1 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.29	-3.01 %	$ 329 M	Britain
CEL-SCI Corporation CVM	2.14 M	$ 3.47	-1.7 %	$ 221 M	USA
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
Denali Therapeutics DNLI	7.8 M	$ 19.74	-12.17 %	$ 3.25 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	546 K	$ 1.09	-9.17 %	$ 22.4 M	Israel
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Equillium EQ	116 K	$ 2.06	-	$ 118 M	USA
Esperion Therapeutics ESPR	105 K	$ 2.85	3.26 %	$ 592 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 23.45	-1.64 %	$ 631 M	USA
China SXT Pharmaceuticals SXTC	82.3 K	$ 1.32	-5.2 %	$ 1.88 M	China
CRISPR Therapeutics AG CRSP	19.5 M	$ 47.55	0.98 %	$ 4.28 B	Schweiz
Arbutus Biopharma Corporation ABUS	363 K	$ 4.45	-1.77 %	$ 853 M	Canada
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA